Alfa Cytology has announced cancer diagnostic biomarker development services to enhance precision in oncology research.   Alfa Cytology, a pioneering biotech firm comprising an interdisciplinary team of scientists, bioinformaticians, and oncologists, has recently introduced its cancer diagnostic biomarker development services to advance personalized...